Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Ripretinib in patients with advanced gastrointestinal str... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial
0
Authors
Jean‐Yves Blay
16 more
Jean‐Yves Blay
•
César Serrano
14 more
•
Margaret Mehren
Published
June 6, 2020
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Oncology
Topics
Medicine
Cancer Oncology
Pathology
Internal Medicine
Surgery
Show all topics
DOI
10.1016/s1470-2045(20)30168-6
License
publisher-specific-oa
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Oncology
Topics
Medicine
Cancer Oncology
Pathology
Internal Medicine
Surgery
Show all topics
DOI
10.1016/s1470-2045(20)30168-6
License
publisher-specific-oa
